They are only registering 500,000 shares of Cytrx's share shares. They own about 5 million of them. Since they are not healthy financially, they will continue to be a burden on the stock, as they may need to part with more for the cash. I just wish the company was away from them.
This securities sales will give them needed money, but this is still not a healthy market. I think they have a great story to tell about their potential. Unfortunately, I think they'll be selling stock at $3 a share to get the deal done. I guess Kriegsman figured that out before I did!